Access to Codexis information for the investment community
Codexis, Inc. (Nasdaq: CDXS), is a leading developer of biocatalysts for the pharmaceutical and fine chemical industries. Codexis utilizes its proprietary CodeEvolver® directed evolution technology platform and CodeXporter® enzyme production platform, for the discovery, identification, optimization, and efficient production of enzymes for its customers. Customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com
|There are currently no events scheduled.|
|View more events >>|
|Receive E-mail Alerts|
|You may automatically receive Codexis, Inc. financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit. The next page will display a menu of options.|
To change your e-mail options at any time, re-enter your e-mail address and click Submit, then adjust your form entries.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.